<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Genomic DNA from 154 unrelated individuals with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> was evaluated for mutations in the fibroblast growth factor receptor 3 (FGFR3) transmembrane domain </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> but one, an atypical case, were found to have a glycine-to-arginine substitution at codon 380 </plain></SENT>
<SENT sid="2" pm="."><plain>Of these, 150 had a G-to-A transition at nt 1138, and 3 had a G-to-C transversion at this same position </plain></SENT>
<SENT sid="3" pm="."><plain>On the basis of estimates of the prevalence of <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e>, the mutation rate at the FGFR3 1138 guanosine nucleotide is two to three orders of magnitude higher than that previously reported for tranversions and transitions in CpG <z:chebi fb="0" ids="47885">dinucleotides</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>To date, this represents the most mutable single nucleotide reported in the human genome </plain></SENT>
<SENT sid="5" pm="."><plain>The homogeneity of mutations in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> is unprecedented for an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disorder and may explain the relative lack of <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in the <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> phenotype </plain></SENT>
</text></document>